AACR Project GENIE: Governance
The project is governed by a steering committee, with a representative from each of the participating institutions, one of whom is the chairperson. The AACR chief executive officer or his or her designee, the AACR president or his or her designee, and a member of the AACR Science Policy and Government Affairs and Clinical and Translational Cancer Research Committees also serve on the project steering committee. The steering committee reports to an external advisory board, and the AACR board of directors. The Steering Committee comprises a representative from each of the 19 participating institutions. The Executive Committee comprises a smaller set of voting members that handle more time-sensitive decisions.
Charles L. Sawyers, MD
Chair, Human Oncology and Pathogenesis Program
Marie-Josée and Henry R. Kravis Chair
Philippe Bedard, MD, FRCPC
(2021-2023)Associate Professor of Medicine
University of Toronto
James L. Abbruzzese
Professor of Medicine
Chief, Division of Medical Oncology
Duke University School of Medicine
Jean Abraham
Director of Cambridge Breast Cancer Unit
Co-lead of the NIHR Cambridge BRC Cancer
University of Cambridge
Karen A. Pinilla Alba
Medical Oncologist and Clinical Researcher
Department of Oncology
University of Cambridge
Fabrice Andre, MD, PhD
Professor, Department of Medical Oncology
Institut Gustave Roussy
Alexander Baras
Director, Pathology Informatics
Associate Professor of Pathology
Johns Hopkins School of Medicine
Lisa M. Coussens
AACR Past President
OHSU Knight Cancer Institute
Oregon Health and Science University
Christina Curtis, PhD
Professor of Medicine, Genetics, and Biomedical Data Science
Stanford University
Margaret Foti, PhD, MD (hc)
Chief Executive Officer
American Association for Cancer Research
Kevin Haigis, PhD
Associate Professor of Medicine, Harvard Medical School
Chief Scientific Officer
Dana-Farber Cancer Institute
Brian Henick
Associate Director of Experimental Therapeutics
Director of Translational Research in Aerodigestive Cancers in Medical Oncology
Columbia University
Marilyn Li, MD
Vice Chief, Division of Genomic Diagnostics
Director, Cancer Genomic Diagnostics
Children’s Hospital of Philadelphia
Shannon Jones McCall, MD
Associate Professor of Pathology
Duke University
Gerrit Meijer, MD, PhD
Professor of Oncologic Pathology
Netherlands Cancer Institute, Amsterdam
Christine Micheel
Research Assistant Professor of Medicine
Division of Hematology/Oncology
Vanderbilt University Medical Center
Jeremy Segal, MD, PhD
Associate Professor of Pathology
University of Chicago Medical Center
Alejandro Sweet-Cordero, MD
Professor of Pediatrics
Director, Molecular Oncology Initiative
Co-leader, Pediatric Malignancies Program
UCSF Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
Walter Urba, MD, PhD
Director, Cancer Research, Robert W. Franz Cancer Research Center
Earle A. Chiles Research Institute
Providence Cancer Center
Ana Vivancos
Research Scientist, Computational Oncology Group
Sage Bionetworks
Principal Investigator, Oncology Data Science (ODysSey) Group
Vall d’Hebron Institute of Oncology
Zenta Walther, MD, PhD
Clinical Director at YNHH Tumor Profiling Laboratory
Director of Molecular Genetic Pathology Fellowship Program
Yale School of Medicine
Wei Zhang
Director of Center for Cancer Genomics and Precision Oncology
Wake Forest School of Medicine
* Member also serves on Executive Committee
More information
If you have questions or require more information, please contact [email protected].